tiprankstipranks
Trending News
More News >
NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
US Market

NewAmsterdam Pharma Company (NAMS) Technical Analysis

Compare
248 Followers

Technical Sentiment

Overall Consensus
Sell
8Bullish
2Neutral
12Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
NewAmsterdam Pharma Company’s (NAMS) Moving Averages Convergence Divergence (MACD) indicator is -0.78, suggesting NewAmsterdam Pharma Company is a Buy.
NewAmsterdam Pharma Company’s (NAMS) 20-Day exponential moving average is 33.12, while NewAmsterdam Pharma Company’s (NAMS) share price is $29.86, making it a Sell.
NewAmsterdam Pharma Company’s (NAMS) 50-Day exponential moving average is 33.75, while NewAmsterdam Pharma Company’s (NAMS) share price is $29.86, making it a Sell.

NewAmsterdam Pharma Company (NAMS) Pivot Points

Mar 09, 2026, 09:12 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
28.67
29.16
29.65
30.14
30.63
31.12
31.61
Fibonacci
29.16
29.53
29.77
30.14
30.51
30.75
31.12
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

NewAmsterdam Pharma Company (NAMS) Moving Averages

Mar 09, 2026, 09:12 AM
Period
Simple
Exponential
MA5
30.88Sell
31.07Sell
MA10
33.13Sell
32.27Sell
MA20
34.02Sell
33.12Sell
MA50
33.68Sell
33.75Sell
MA100
35.43Sell
33.14Sell
MA200
29.32Buy
28.86Buy
NewAmsterdam Pharma Company’s (NAMS) 10-Day exponential moving average is 32.27, while NewAmsterdam Pharma Company’s (NAMS) share price is $29.86, making it a Sell.
NewAmsterdam Pharma Company’s (NAMS) 100-Day exponential moving average is 33.14, while NewAmsterdam Pharma Company’s (NAMS) share price is $29.86, making it a Sell.
NewAmsterdam Pharma Company’s (NAMS) stock price is $29.86 and NewAmsterdam Pharma Company’s (NAMS) 50-day simple moving average is 33.68, creating a Sell signal.
NewAmsterdam Pharma Company’s (NAMS) stock price is $29.86 and NewAmsterdam Pharma Company’s (NAMS) 100-day simple moving average is 35.43, creating a Sell signal.
NewAmsterdam Pharma Company’s (NAMS) stock price is $29.86 and NewAmsterdam Pharma Company’s (NAMS) 200-day simple moving average is 29.32, creating a Buy signal.

NewAmsterdam Pharma Company (NAMS) Technical Indicators

Mar 09, 2026, 09:12 AM
Name
Value
Implied Action
RSI (14)
35.61
Neutral
STOCH (9,6)
11.12
Buy
STOCHRSI (14)
9.90
Buy
MACD (12,26)
-0.78
Buy
ADX (14)
16.50
Buy
Williams %R
-90.18
Buy
CCI (14)
-190.03
Buy
ATR (14)
1.82
-
Ultimate Oscillator
45.42
Neutral
ROC
-13.77
Sell
NewAmsterdam Pharma Company’s (NAMS) Relative Strength Index (RSI) is 35.61, creating a Neutral signal.
NewAmsterdam Pharma Company’s (NAMS) Trend Strength Indicator (ADX) is 16.50, creating a Buy signal.
NewAmsterdam Pharma Company’s (NAMS) Commodity Channel Index (CCI) is -190.03, creating a Buy signal.
NewAmsterdam Pharma Company’s (NAMS) Price Rate of Change (ROC) is -13.77, creating a Sell signal.

FAQ

Is NAMS a Buy, Hold, or Sell?
Based on NAMS’s technical indicators, NAMS is a Sell.
    What is NAMS’s RSI (14)?
    NAMS’s RSI (14) is 35.61, which suggests NAMS is a Neutral.
      What is NAMS’s MACD?
      NAMS’s MACD is -0.78, which suggests NAMS is a Buy.
        What is NAMS’s 5-day moving average?
        NAMS’s 5-day moving average is 30.88, which suggests NAMS is a Sell.
          What is NAMS’s 20-day moving average?
          NAMS 20-day moving average is 34.02, which suggests NAMS is a Sell.
            What is NAMS’s 50-day moving average?
            NAMS’s 50-day moving average is 33.68, which suggests NAMS is a Sell.
              What is NAMS’s 200-day moving average?
              NAMS’s 200-day moving average is 29.32, which suggests NAMS is a Buy.
                What is NAMS’s Williams % R (14)?
                NAMS’s Williams % R (14) is -90.18, which suggests NAMS is a Buy.
                  What is NAMS’s CCI (14)?
                  NAMS’s CCI (14) is -190.03, which suggests NAMS is a Buy.